Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie
By B. Chesebro, M. Trifilo, R. Race, Kimberly Meade-White, Chao-yi Teng, R. Lacasse, L. Raymond, C. Favara, G. Baron, S. Priola and 3 more. Science, 2005
633 citations recorded by the source corpus.
Subfields: Molecular Biology, Neurology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/81669386e0ebad4d5b0c59e555746b88ea17aaed
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Tracy O'Connor
- A. Aguzzi
Citations in the corpus
- Protein aggregation diseases: pathogenicity and therapeutic perspectives (2010, background): “This concept is not new to the prion field: it has long been known that PrP Sc -mediated neuronal toxicity is completely abrogated in the absence of Prnp expression, even in experimental paradigms in which PrP Sc can still accumulat”